HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Arg(15,20,21)-Leu(17)- vasoactive intestinal peptide-GRR

putative drug delivery system for VIP therapy
Also Known As:
vasoactive intestinal peptide-GRR, Arg(15,20,21)-Leu(17)-; (R(15,20,21),L(17))-VIP-GRR; 15,20,21-Arg-17-Leu-VIP-GRR; IK 312532; IK-312532; IK312532; VIP-GRR, arginyl(15,20,21)-leucyl(17)-
Networked: 5 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yamada, Shizuo: 5 articles (11/2010 - 12/2004)
2. Onoue, Satomi: 5 articles (11/2010 - 12/2004)
3. Mizumoto, Takahiro: 3 articles (11/2010 - 09/2009)
4. Misaka, Shingen: 3 articles (11/2010 - 09/2009)
5. Ohmori, Yuki: 3 articles (09/2009 - 12/2004)
6. Aoki, Yosuke: 2 articles (11/2010 - 01/2010)
7. Kuwahara, Atsukazu: 2 articles (11/2010 - 01/2010)
8. Karaki, Shin-ichiro: 2 articles (11/2010 - 01/2010)
9. Yajima, Takehiko: 2 articles (09/2009 - 12/2004)
10. Kashimoto, Kazuhisa: 2 articles (12/2004 - 12/2004)

Related Diseases

1. Pheochromocytoma
2. Chronic Obstructive Pulmonary Disease (COPD)
3. Asthma (Bronchial Asthma)
4. Pneumonia (Pneumonitis)
5. Lung Diseases (Lung Disease)

Related Drugs and Biologics

1. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)
2. Biological Markers (Surrogate Marker)
3. Smoke
4. Peptides
5. Ovalbumin
6. Peroxidases

Related Therapies and Procedures

1. Dry Powder Inhalers
2. Respiratory Therapy (Therapy, Respiratory)